Six details:
1. The joint investment includes Hellman & Friedman, Bain Capital Private Equity and Bain Capital Tech Opportunities; Veritas Capital and Evergreen Coast Capital, an Elliott Investment Management affiliate, will each keep a minority investment in Athenahealth.
2. Veritas and Elliott acquired Athenahealth in February 2019 for $5.7 billion. Under the purchase, the company went private and removed its common stock from Nasdaq.
3. In September, Bloomberg reported that Veritas and Elliott were considering selling Athenahealth or filing an initial public offering.
4. Bob Segert, chairman and CEO of Athenahealth, will continue leading the company alongside its current management team.
5. The investment is expected to be completed in the first quarter of 2022 and is subject to regulatory approvals and customary closing conditions.
6. Athenahealth is partnered with more than 140,000 ambulatory care providers across the U.S.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
